Detection of individual differences in radiation-induced apoptosis of peripheral blood lymphocytes in normal individuals, ataxia telangiectasia homozygotes and heterozygotes, and breast cancer patients after radiotherapy

Radiation Research

Volumn 153, Issue 5 I, 2000, Pages 570-578

  Barber, J B P ^a,b   West, C M L ^a   Kiltie, A E ^a   Roberts, S A ^a   Scott, D ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b VELINDRE CANCER CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; APOPTOSIS; ARTICLE; ATAXIA TELANGIECTASIA; BREAST CANCER; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC PREDISPOSITION; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN CELL; LYMPHOBLAST; MALE; NICK END LABELING; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION RESPONSE; REPRODUCIBILITY;

EID: 0034023642     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/0033-7587(2000)153[0570:DOIDIR]2.0.CO;2     Document Type: Article

References (43)

1. D. Vaux, Toward an understanding of the molecular mechanisms of physiological cell death. Proc. Natl. Acad. Sci. USA 90, 786-789 (1993).
2. R. S. Camplejohn, P. Perry, S. V. Hodgson, G. Turner, A. Williams, C. Upton, C. MacGeoch, S. Mohammed and D. M. Barnes, A possible screening test for inherited p53-related defects based on the apoptotic response of peripheral blood lymphocytes to DNA damage. Br. J. Cancer 72, 654-662 (1995).
3. N. E. Crompton and M. Ozsahin, A versatile and rapid assay of radiosensitivity of peripheral blood leukocytes based on DNA and surface-marker assessment of cytotoxicity. Radiat. Res. 147, 55-60 (1997).
4. A. M. Taylor, D. G. Harnden, C. F. Arlett, S. A. Harcourt, A. R. Lehmann, S. Stevens and B. A. Bridges, Ataxia telangiectasia: a human mutation with abnormal radiation sensitivity. Nature 258, 427-429 (1975).
5. I. Turesson, Individual variation and dose dependency in the progression rate of skin telangiectasia. Int. J. Radiat. Oncol. Biol. Phys. 19, 1569-1574 (1990).
6. J. Johansen, S. M. Bentzen, J. Overgaard and M. Overgaard, Relationship between the in vitro radiosensitivity of skin fibroblasts and the expression of subcutaneous fibrosis, telangiectasia, and skin erythema after radiotherapy. Radiother. Oncol. 40, 101-109 (1996).
7. N. G. Burnet, J. Nyman, I. Turesson, R. Wurm, J. R. Yarnold and J. H. Peacock, The relationship between cellular radiation sensitivity and tissue response may provide the basis for individualising radiotherapy sched-ules. Radiother. Oncol. 33, 228-238 (1994).
8. F. B. Geara, L. J. Peters, K. K. Ang, J. L. Wike and W. A. Brock, Prospective comparison of in vitro normal cell radiosensitivity and normal tissue reactions in radiotherapy patients. Int. J. Radiat. Oncol. Biol. Phys. 27, 1173-1179 (1993).
9. C. M. West, S. A. Elyan, P. Berry, R. Cowan and D. Scott, A comparison of the radiosensitivity of lymphocytes from normal donors, cancer patients, individuals with ataxia-telangiectasia (A-T) and A-T heterozygotes. Int. J. Radiat. Biol. 68, 197-203 (1995).
10. L. A. Jones, D. Scott, R. Cowan and S. A. Roberts, Abnormal radiosensitivity of lymphocytes from breast cancer patients with excessive normal tissue damage after radiotherapy: chromosome aberrations after low dose-rate irradiation. Int. J. Radiat. Biol. 67, 519-528 (1995).
11. E. L. Levine, A. Renehan, R. Gossiel, S. E. Davidson, S. A. Roberts, C. Chadwick, D. P. Wilks, C. S. Potten, J. H. Hendry and R. D. Hunter, Apoptosis, intrinsic radiosensitivity and prediction of radiotherapy response in cervical carcinoma. Radiother. Oncol. 37, 1-9 (1995).
12. J. Lera, P. C. Lara, S. Perez, J. L. Cabrera and C. Santana, Tumor proliferation, p53 expression, and apoptosis in laryngeal carcinoma: relation to the results of radiotherapy. Cancer 83, 2493-2501 (1998).
13. P. C. Lara, S. Perez, A. Rey and C. Santana, Apoptosis in carcinoma of the bladder: relation with radiation treatment results. Int. J. Radiat. Oncol. Biol. Phys. 43, 1015-1019 (1999).
14. J. A. Wheeler, L. C. Stephens, C. Tornos, P. J. Eifel, K. K. Ang, L. Milas, P. K. Allen and R. E. Meyn, Jr., Apoptosis as a predictor of tumor response to radiation in stage IB cervical carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 32, 1487-1493 (1995).
15. M. S. Meyn, L. Strasfeld and C. Allen, Testing the role of p53 in the expression of genetic instability and apoptosis in ataxia-telangiectasia. Int. J. Radiat. Biol. 66, S141-S149 (1994).
16. L. Enns, R. D. Barley, M. C. Paterson and R. Mirzayans, Radiosensitivity in ataxia telangiectasia fibroblasts is not associated with deregulated apoptosis. Radiat. Res. 150, 11-16 (1998).
17. E. Duchaud, A. Ridet, D. Stoppa-Lyonnet, N. Janin, E. Moustacchi and F. Rosselli, Deregulated apoptosis in ataxia telangiectasia: association with clinical stigmata and radiosensitivity. Cancer Res. 56, 1400-1404 (1996).
18. W. Dahlberg and J. Little, Response of dermal fibroblast cultures from patients with unusually severe responses to radiotherapy and from ataxia telangiectasia heterozygotes to fractionated radiation. Clin. Cancer Res. 1, 785-790 (1995).
19. J. M. Appleby, J. B. Barber, E. Levine, J. M. Varley, A. M. Taylor, T. Stankovic, J. Heighway, C. Warren and D. Scott, Absence of mutations in the ATM gene in breast cancer patients with severe responses to radiotherapy. Br. J. Cancer 76, 1546-1549 (1997).
20. M. Shayeghi, S. Seal, J. Regan, N. Collins, R. Barfoot, N. Rahman, A. Ashton, M. Moohan, R. Wooster and R. Owen, Heterozygosity for mutations in the ataxia telangiectasia gene is not a major cause of radiotherapy complications in breast cancer patients. Br. J. Cancer 78, 922-927 (1998).
21. M. G. Fitzgerald, J. M. Bean, S. R. Hegde, H. Unsal and D. J. Macdonald, Heterozygous ATM mutations do not contribute to early onset of breast cancer. Nat. Genet. 15, 307-309 (1997).
22. D. E. Weeks, M. C. Paterson, K. Lange, B. Andrais, R. C. Davis, F. Yoder and R. A. Gatti, Assessment of chronic gamma radiosensitivity as an in vitro assay for heterozygote identification of ataxia-telangiectasia. Radiat. Res. 128, 90-99 (1991).
23. C. M. Payne, C. G. Bjore, Jr. and D. A. Schultz, Change in the frequency of apoptosis after low- and high-dose X-irradiation of human lymphocytes. J. Leukoc. Biol. 52, 433-440 (1992).
24. P. Fraker, L. King, D. Lill-Elghanian and W. Telford, Quantification of apoptotic event in pure and heterogeneous populations of cells using the flow cytometer. Methods Cell Biol. 46, 57-76 (1995).
25. H. Seki, K. Iwai, H. Kanegane, A. Konno, K. Ohta, A. Yachie, N. Taniguchi and T. Miyawaki, Differential protective action of cytokines on radiation-induced apoptosis of peripheral lymphocyte subpopulations. Cell Immunol. 163, 30-36 (1995).
26. W. Gorczyca, J. Gong and Z. Darzynkiewicz, Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res. 53, 1945-1951 (1993).
27. G. G. Ribeiro, B. Magee, R. Swindell, M. Harris and S. S. Banerjee, The Christie Hospital breast conservation trial: an update at 8 years from inception. Clin. Oncol. 5, 278-283 (1993).
28. P. Rubin, L. S. Constine, L. F. Fajardo, T. L. Phillips and T. H. Wasserman, EORTC Late Effects Working Group. Overview of late effects normal tissues (LENT) scoring system. Radiother. Oncol. 35, 9-10 (1995).
29. M. S. Meyn, Ataxia-telangiectasia and cellular responses to DNA damage. Cancer Res. 55, 5991-6001 (1995).
30. T. J. Jorgensen and Y. Shiloh, The ATM gene and the radiobiology of ataxia-telangiectasia. Int. J. Radiat. Biol. 69, 527-537 (1996).
31. J. M. Lee and A. Bernstein, p53 mutations increase resistance to ionizing radiation. Proc. Natl. Acad. Sci. USA 90, 5742-5746 (1993).
32. M. F. Lavin, Radiosensitivity and oxidative signalling in ataxia telangiectasia: an update. Radiother. Oncol. 47, 113-123 (1998).
33. R. Yao and G. M. Cooper, Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science 267, 2003-2006 (1995).
34. T. Stankovic, P. Weber, G. Stewart, T. Bedenham, J. Murray, P. J. Byrd, P. A. H. Moss and A. M. R. Taylor, Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia. Lancet 353, 26-29 (1999).
35. J. C. Reed, Molecular biology of chronic lymphocytic leukemia. Semin. Oncol. 25, 11-18, (1998).
36. G. Birrell and J. Ramsay, Induction of p53 protein by gamma radiation in lymphocyte lines from breast cancer and ataxia telangiectasia patients. Br. J. Cancer 72, 1096-1101 (1995).
37. D. Scott, J. B. Barber, E. L. Levine, W. Burrill and S. A. Roberts, Radiation-induced micronucleus induction in lymphocytes identifies a high frequency of radiosensitive cases among breast cancer patients: a test for predisposition? Br. J. Cancer 77, 614-620 (1998).
38. R. Parshad, F. Price, V. Bohr, K. Cowans, J. Zujewski and K. Sanford, Deficient DNA repair capacity, a predisposing factor in breast cancer. Br. J. Cancer 74, 1-5 (1996).
39. D. Scott, J. B. P. Barber, A. R. Spreadborough, W. Burrill and S. A. Roberts, Increased chromosomal radiosensitivity in breast cancer patients: a comparison of two assays. Int. J. Radiat. Biol. 75, 1-10 (1999).
40. S. Roberts, A. Spreadborough, B. Bulman, J. Barber, G. Evans and D. Scott, Inheritance of a marker of low penetrance predisposition genes in breast cancer? Am. J. Hum. Genet. 65, 784-794 (1999).
41. J. Schwartz and R. Jordan, Selective elimination of human lymphoid cells with unstable chromosome aberrations by p53-dependent apoptosis. Carcinogenesis 18, 201-205 (1997).
42. L. Mitchell and D. Scott, G2 chromosomal radiosensitivity in fibroblasts of ataxia-telangiectasia heterozygotes and a Li-Fraumeni syndrome patient with radioresistant cells. Int. J. Radiat. Biol. 72, 435-438 (1997).
43. L. Wang, Y. Cui, B. I. Lord, S. A. Roberts, C. S. Potten, J. H. Hendry and D. Scott, Gamma-ray-induced cell killing and chromosome abnormalities in the bone marrow of p53-deficient mice. Radiat. Res. 146, 259-266 (1996).